Longwood Healthcare Leaders Fall Webconference

September 21 - 22, 2022

The Longwood Healthcare Leaders Fall webconference brings together leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors for an off-the-record forum focused on accelerating the translation of discoveries into medicines to help patients.

Registered participants are invited to join a cocktail party

with Maura Healey, leading MA gubernatorial candidate

at The Country Club in Brookline, MA,
site of the
2022 US Open Golf Championship.

Featured Speakers

Regulatory, Government, & Academics

BioPharma CEOs

R&D Leaders

BD & Strategy Leaders

 
 

Wednesday, September 21, 2022

7:00 am ET

LONGWOOD FUND INTRODUCTION

David Steinberg, General Partner, Longwood Fund

7:30 am ET

MOVING BEYOND NEWCO

Michael Ackermann, Chair, Tarsus

Laurence Blumberg, former CEO, Arch Oncology

Hiro Kimura, Investment Director, Astellas Pharma

John McCabe, CFO & COO, DEM Bio

Moderator: Luba Greenwood, CEO, Kojin Therapeutics

8:00 am ET

RNAi REVOLUTION: THE ALNYLAM STORY

John Maraganore, former CEO, Alnylam

Barry Greene, CEO, Sage; former President, Alnylam 

Moderator: Christoph Westphal, founding CEO, Alnylam; General Partner, Longwood Fund

8:20 am ET

BIG BIOPHARMA PIPELINE SOURCING

Rich ColvinCMO, Bluebird Bio

Kathy Fernando, Head, mRNA Scientific Strategy, Head, WRDM Operations, Pfizer

Heather Huet, Head, Oncology Strategy & Operations, Takeda
Gilmore O'NeillCEO, Editas 

Brandon TurunenHead, US Chemical Biology, GlaxoSmithKline

Moderator: John Westwood, Partner & Global Leader, Life Sciences, Oliver Wyman

8:50 am ET

APPROVALS: INSIGHTS, OUTLOOK, AND COMMITMENT TO PATIENTS

Kabir Nath, CEO, Compass Pathways

Andrew Obenshain, CEO, bluebird bio

Ryan Richardson, Chief Strategy Officer, BioNTech

Moderator: Jeremy Levin, CEO, Ovid Therapeutics

9:20 am ET

EARLY PREPARATION FOR PARTNERING

Jennifer Cayer, CBO, Pulmocide

Jason Coloma, CEO, Maze Therapeutics

Matt GlineCEO, Roivant Sciences

Kate Haviland, CEO, Blueprint Medicines 

Moderator: Robert LaCaze, CEO, Mnemo Therapeutics

9:50 am ET

CREATING A WORLD WITHOUT DISEASE

Anne KlibanskiPresident & CEO, Mass General Brigham

Peter Lebowitz, SVP & Head, Global Oncology, Janssen

Richard PaulsonCEO, Karyopharm

Cindy Perettie, Head, Molecular Labs, Roche Diagnostics

Jan Pinkas, CSO, Pyxis Oncology

Moderator: Chen Schor, President & CEO, Adicet Bio

10:20 am ET

REGULATORY & INDUSTRY ROUNDTABLE

Mikael DolstenCSO & President, WW Research, Development and Medical, Pfizer

Peter Marks, Director, CBER, FDA

Christoph Westphal, General Partner, Longwood Fund

10:40 am ET

THE NEXT WAVE OF TARGETED THERAPIES

Stewart Campbell, CEO, Axial Therapeutics

Judy Chou, CEO, AltruBio

Sandra Glucksmann, CEO, Cedilla Therapeutics

Rick Morgan, CSO, Be Bio

Kathy Seidl, Head, Oncology Drug Discovery, Takeda

Moderator: Armon Sharei, CEO, SQZ Biotech

11:15 am ET

R&D COLLABORATION

Hans Clevers, Head, pRED, Roche

Elliot EhrichPresident, Skyhawk Therapeutics

Jak Knowles, CEO, Affini-T Therapeutics

Greg LaRosa, Head, Scientific Research Rare Disease, Pfizer

Moderator: Beth Shafer, Head, R&D BD, GI, NS, DDS & Externalizations, Takeda

11:50 am ET

SCIENTIFIC INNOVATION: LAUNCHING COMPANIES FROM ACADEMIA

Sangeeta Bhatia, Director, Marble Center for Cancer Nanomedicine, Koch Institute at MIT

Christina Coughlin, CEO, CytoImmune Therapeutics

David DonabedianCo-Founder, Interim President & CEO, DEM Bio

Mark Leuchtenberger, CEO, SpyBiotech

Kai Wucherpfennig, Chair, Cancer Immunology & Virology, Dana-Farber Cancer Institute

Moderator: Joel Marcus, Executive Chair & Founder, Alexandria Real Estate Equities

12:25 pm ET

SOURCING AND IDENTIFYING NOVEL TECHNOLOGY

Juliette Han, COO, Cambrian Biopharma

Nik Kojic, CEO, Oryon Cell Therapies

Anand Parikh, CEO, Faeth Therapeutics

Ryan Schoenfeld, CEO, The Mark Foundation for Cancer Research

Tom WiltonCBO, Carisma Therapeutics

Moderator: Bruce Sunstein, Partner, Sunstein LLP

1:00 pm ET

EXPEDITING RESEARCH FOR TREATMENTS AND CURES

Raj Devraj, CEO, Rectify Pharmaceuticals

Rachelle Jacques, CEO, Akari

Saul Kato, CEO, Herophilus

Josh Lehrer, CEO, Graphite Bio

Shiladitya Sengupta, Associate Professor, Medicine, Harvard Medical School 

Moderator: Gaurav Shah, CEO, Rocket Pharmaceuticals

1:30 pm ET

FIRESIDE CHAT: PATIENT ACCESS

Julie Gerberding, CEO, Foundation for the NIH; former director, CDC

David Loew, CEO, Ipsen

Moderator: Maria Whitman, Managing Principal, Global Pharmaceutical & Biotech Industry, ZS Associates

1:50 pm ET

DESIGNING THE DEAL

Sandy Mong, SVP, BD & Operations, Curie Therapeutics

Steve Perrin, President & CSO, Eledon Pharmaceuticals

Bob Silverman, CBO, Rejuveron

Moderator: Stuart Mackey, Global Head, BD, Daiichi Sankyo

2:20 pm ET

DRUG DISCOVERY SCIENCES

Marcelo Bigal, CEO, Ventus Therapeutics

Jane Grogan, CSO, Graphite Bio

Stefen Laukien, CEO, Retroviral Therapeutics

Marie-Claire Peakman, Executive Director, Emerging Science & Innovation WWRD, Pfizer Ventures

David Southwell, CEO, TScan Therapeutics

Moderator: Iris Grossman, CSO, Eleven Therapeutics

2:50 pm ET

ACCELERATING THE PATH TO PATIENT CARE

Jennifer Buell, CEO, MiNK

Jamie Dowd, North America Health Lead, Weber Shandwick

John Renger, CSO, Cerevel

Kevin Tabb, CEO, Beth Israel Lahey Health

Moderator: David Weinreich, EVP, Head, Global Clinical Development, Regeneron

3:20 pm ET

FIRESIDE CHAT

John Lepore,SVP, Head of Research, GlaxoSmithKline

David Reese, EVP, R&D, Amgen

Moderator: Aaron Mitchell, Principal, ZS Associates

3:40 pm ET

EXTERNAL INNOVATION

Diana Gallagher, Head, External Innovation, Biogen 

Jim List, Global Therapeutic Area Head, Cardiovascular, Metabolism, Retina & Pulmonary Hypertension, Janssen

Philippe Lopes-Fernandes, CBO, Ipsen

Amanda Wagner, CEO, Immunitas

Moderator: Chandra Ramanathan, Global Head, Innovation Hubs, Danaher

4:10 pm ET

VENTURE INVESTING: DEVELOPING THE SYNDICATE

Vineeta Agarwala, General Partner, a16z

Christine BrennanManaging Director, Vertex Ventures HC

Ansbert Gadicke, Managing Director, MPM Capital

Nina Kjellson, General Partner, Canaan

Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund 

4:40 pm ET

LONGWOOD FUND UPDATE 

Lizzie Ngo, Principal, Longwood Fund

 

Fall Webconference Agenda

​This off-the-record meeting is focused on accelerating the translation of discoveries into medicines to help patients. Substantial donations enabled by these meetings benefit humanitarian efforts in Ukraine among other charities. 

 

Thursday, September 22, 2022

7:00 am ET

LONGWOOD FUND INTRODUCTION

Christoph Westphal, General Partner, Longwood Fund

7:30 am ET

HARNESSING BIOMEDICAL INNOVATION

John Flavin, Chair, Pyxis Oncology

Trish Hurter, CEO, Lyndra

Joel Schneider, CEO, Carbon Biosciences

Krishnan Viswanadhan, President & COO, Be Bio

Moderator: Manuel Aivado, CEO, Aileron

8:00 am ET

PORTFOLIO COMPANY PRESENTATION

Amanda Wagner, CEO, Immunitas

Brian Fenton, CEO, Photys Therapeutics

8:20 am ET

GLOBAL MARKETS: WORKING ACROSS BORDERS

Al Beardsley, Chief Operating Officer, Galera Therapeutics 

Keting Chu, CEO, Blue Jay Therapeutics

Rick Russell, CEO, Tract Pharmaceuticals

Cecilia Schott, WW Head, Precision Diagnostics, Novartis

Moderator: Zhen Su, CEO, Marengo Therapeutics

8:50 am ET

ACCELERATING DRUG DEVELOPMENT

Christian Antoni, Chief Development Officer, EQRx

Matt GevaertCEO, Kiyatec

Priya Singhal, Interim Head R&D, SVP, Global Head, Safety & Regulatory Sciences, Biogen

Pamela Stetkiewicz, COO, Arbor Biotechnologie

Moderator: James Sapirstein, CEO, First Wave BioPharmas

9:20 am ET

PREPARING FOR THE FUTURE OF R&D

Fabrice Chouraqui, CEO, Cellarity

Nenad Grmusa, SVP, Head R&D Strategy & External Innovation, CFO R&D, Takeda

Phil Larsen, Global Head, Research & Early Development, Bayer Pharmaceuticals

Raquel Mura, Head, R&D, North America, Sanofi

Al Sandrock, CEO, Voyager Therapeutics

Moderator: Luigi Gentile, CRO, BenchSci

9:50 am ET

BUILDING GLOBAL BIOPHARMAS

Janice Chen, CTO, Mammoth

Jonathan Gootenberg, Fellow, McGovern Institute

Ed Holson, Co-Founder & CSO, Photys Therapeutics

Amit Rakhit, CEO, Flare Therapeutics

Moderator: Bettina Cockroft, CMO, Sangamo

10:20 am ET